Nuclear pore complex-interacting protein family member A8 (NPIPA8)

NPIPA8 is a putative member of the morpheus gene family found on human chromosome 16p11.2, more specifically part of a segmentally duplicated region (LCR16a) rich in related NPIP genes. These genes are not established NPC core components, and their precise function is unclear. The core nuclear pore complex, responsible for nucleocytoplasmic transport, is formed by about 30 nucleoporins (NUPs, e.g., NUP93, NUP96, NUP205, etc.)—none of which are NPIPA8 or NPIP gene products[1][2][3][4]. Instead, the NPIP (nuclear pore complex interacting protein) family is known from evolutionary genomics studies for expansion in primate lineages and is thought to represent nuclear-enriched proteins of unknown or variable function; there is no evidence they act as transport receptors, channels, or classical NPC components. No data supports NPIPA8 being: - An enzyme, receptor, transporter, channel, or direct disease target. - Involved in any well-defined biological pathway or mechanism. - A biomarker for disease, drug response, or patient selection. - The subject of any pharmacological agent or small molecule drug interaction. NPIPA8 (nuclear pore complex-interacting protein family member A8) refers to a gene of largely unknown function, not a canonical protein or established drug target. It is not a known nucleoporin, therapeutic target, or disease gene, and is primarily cited in genomic segmental duplication contexts. All functional, disease, drug, and safety fields should be marked null for structured data panels. No curated literature currently supports NPIPA8 as a validated protein, drug target, or functional nuclear pore complex component[1][2][3][4].

Other names

NPIPA8LCR16a9Morpheus gene family member 9NPIPA7Nuclear pore complex-interacting protein family member A7